These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32525003)

  • 1. Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy.
    Chen D; Patel RR; Verma V; Ramapriyan R; Barsoumian HB; Cortez MA; Welsh JW
    Radiother Oncol; 2020 Sep; 150():114-120. PubMed ID: 32525003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer.
    Cho Y; Park S; Byun HK; Lee CG; Cho J; Hong MH; Kim HR; Cho BC; Kim S; Park J; Yoon HI
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1065-1073. PubMed ID: 31476418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy.
    Zhao Q; Li T; Chen G; Zeng Z; He J
    Front Oncol; 2019; 9():1488. PubMed ID: 32039000
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma.
    Liu J; Zhao Q; Deng W; Lu J; Xu X; Wang R; Li X; Yue J
    Radiat Oncol; 2017 May; 12(1):90. PubMed ID: 28558844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy.
    Yang G; Yoon HI; Lee J; Kim J; Kim H; Cho J; Lee CG; Chang JS; Cho Y; Kim JS; Kim KH
    Radiother Oncol; 2023 Dec; 189():109934. PubMed ID: 37783291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early lymphocyte levels and low doses radiation exposure of lung predict lymphopenia in radiotherapy for lung cancer.
    Kuncman Ł; Pajdziński M; Smółka K; Bilski M; Socha J; Stando R; Peszyńska-Piorun M; Korab K; Jereczek-Fossa BA; Fijuth J
    Front Immunol; 2024; 15():1426635. PubMed ID: 39148729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphopenia associated with whole-brain radiotherapy and its effects on clinical outcomes of patients with brain metastases.
    Wang Y; Zeng W; Xie W; Zhao W; Chen Y; Yang G
    Sci Rep; 2024 Sep; 14(1):21315. PubMed ID: 39266704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy.
    Reddy AV; Deek MP; Jackson JF; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
    Radiat Oncol; 2021 Dec; 16(1):242. PubMed ID: 34952610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy.
    Cheng X; Chen B; Wang S; Zhang J; Zhu J; Liu M; Liu S; Xi M
    Oncologist; 2023 Aug; 28(8):e606-e616. PubMed ID: 37061835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy.
    Joseph N; McWilliam A; Kennedy J; Haslett K; Mahil J; Gavarraju A; Mistry H; Van Herk M; Faivre-Finn C; Choudhury A
    Radiother Oncol; 2019 Jun; 135():115-119. PubMed ID: 31015156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of the Kinetics of Radiation-Induced Lymphocyte Loss in Patients Treated with External Beam Radiation Therapy.
    Ellsworth SG; Yalamanchali A; Zhang H; Grossman SA; Hobbs R; Jin JY
    Radiat Res; 2020 Jan; 193(1):73-81. PubMed ID: 31675264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer.
    Wu G; Baine MJ; Zhao N; Li S; Li X; Lin C
    BMC Cancer; 2019 Oct; 19(1):977. PubMed ID: 31640607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors.
    Pike LRG; Bang A; Mahal BA; Taylor A; Krishnan M; Spektor A; Cagney DN; Aizer AA; Alexander BM; Rahma O; Balboni T; Ott PA; Hodi FS; Schoenfeld JD
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):142-151. PubMed ID: 30227198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials.
    Chen D; Verma V; Patel RR; Barsoumian HB; Cortez MA; Welsh JW
    Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):196-203. PubMed ID: 32036004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphopenia predicts response to stereotactic radiosurgery in lung cancer patients with brain metastases.
    Li YD; Lamano JB; Kaur G; Lamano JB; Veliceasa D; Biyashev D; Kruser T; Bloch O
    J Neurooncol; 2019 Jun; 143(2):337-347. PubMed ID: 30982197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of absolute lymphocyte count in patients with advanced esophageal cancer treated with immunotherapy: a retrospective analysis.
    Zhao Q; Bi Y; Xue J; Liu Y; Zhu J; Qin S
    Ann Transl Med; 2022 Jul; 10(13):744. PubMed ID: 35957729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and prognostic factors of stereotactic body radiotherapy combined with immunotherapy for pulmonary oligometastases: a preliminary retrospective cohort study.
    Piao MN; Xie J; Jin MM; Ma XT; Dou Z; Wang JP; Li JL
    Transl Lung Cancer Res; 2024 Aug; 13(8):1950-1963. PubMed ID: 39263027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer.
    Cho O; Oh YT; Chun M; Noh OK; Lee HW
    Tumour Biol; 2016 Jan; 37(1):971-8. PubMed ID: 26264618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count.
    Xie X; Gong S; Jin H; Yang P; Xu T; Cai Y; Guo C; Zhang R; Lou F; Yang W; Wang H
    Radiat Oncol; 2020 Mar; 15(1):65. PubMed ID: 32169088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated Radiotherapy-Related Lymphopenia Is Associated With Worse Survival in Unresectable Intrahepatic Cholangiocarcinoma.
    Lee G; Kim DW; Smart AC; Horick NK; Eyler CE; Roberts HJ; Pathak P; Goyal L; Franses J; Heather JM; Hwang WL; Grassberger C; Klempner SJ; Drapek LC; Allen JN; Blaszkowsky LS; Parikh AR; Ryan DP; Clark JW; Hong TS; Wo JY
    Am J Clin Oncol; 2024 Aug; 47(8):373-382. PubMed ID: 38767086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.